NVLG Stock Overview
Provides healthcare services in Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Novolog (Pharm-Up 1966) Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪1.47 |
| 52 Week High | ₪1.96 |
| 52 Week Low | ₪1.35 |
| Beta | 0.48 |
| 1 Month Change | -9.18% |
| 3 Month Change | -22.42% |
| 1 Year Change | -2.77% |
| 3 Year Change | -53.21% |
| 5 Year Change | -31.35% |
| Change since IPO | -9.57% |
Recent News & Updates
Recent updates
We Think Novolog (Pharm-Up 1966)'s (TLV:NVLG) Profit Is Only A Baseline For What They Can Achieve
Apr 02
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Nov 05Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital
Jul 25I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease
May 07Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend
Apr 14Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality
Mar 24Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 09How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?
Feb 15
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years
Jan 25How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?
Dec 29With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting
Dec 08Shareholder Returns
| NVLG | IL Healthcare | IL Market | |
|---|---|---|---|
| 7D | -2.4% | -1.4% | 2.6% |
| 1Y | -2.8% | 6.6% | 25.9% |
Return vs Industry: NVLG underperformed the IL Healthcare industry which returned 6.6% over the past year.
Return vs Market: NVLG underperformed the IL Market which returned 25.9% over the past year.
Price Volatility
| NVLG volatility | |
|---|---|
| NVLG Average Weekly Movement | 5.1% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in IL Market | 8.3% |
| 10% least volatile stocks in IL Market | 3.6% |
Stable Share Price: NVLG has not had significant price volatility in the past 3 months compared to the IL market.
Volatility Over Time: NVLG's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 955 | Aviad Bossi | www.novolog.co.il |
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of medicine and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment.
Novolog (Pharm-Up 1966) Ltd Fundamentals Summary
| NVLG fundamental statistics | |
|---|---|
| Market cap | ₪752.98m |
| Earnings (TTM) | ₪39.54m |
| Revenue (TTM) | ₪2.02b |
19.0x
P/E Ratio0.4x
P/S RatioIs NVLG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NVLG income statement (TTM) | |
|---|---|
| Revenue | ₪2.02b |
| Cost of Revenue | ₪1.84b |
| Gross Profit | ₪180.78m |
| Other Expenses | ₪141.24m |
| Earnings | ₪39.54m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.077 |
| Gross Margin | 8.94% |
| Net Profit Margin | 1.96% |
| Debt/Equity Ratio | 0% |
How did NVLG perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield-662%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/13 20:06 |
| End of Day Share Price | 2025/04/10 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novolog (Pharm-Up 1966) Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elena Rogovin | Chardan Capital Markets, LLC |